Neurocrine Biosciences (FRA:NB3) Days Payable : 982.55 (As of Dec. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Neurocrine Biosciences Days Payable?

Neurocrine Biosciences's average Accounts Payable for the three months ended in Dec. 2024 was €96 Mil. Neurocrine Biosciences's Cost of Goods Sold for the three months ended in Dec. 2024 was €9 Mil. Hence, Neurocrine Biosciences's Days Payable for the three months ended in Dec. 2024 was 982.55.

The historical rank and industry rank for Neurocrine Biosciences's Days Payable or its related term are showing as below:

FRA:NB3' s Days Payable Range Over the Past 10 Years
Min: 922.15 Med: 1382.98 Max: 1967.57
Current: 1145.46

During the past 13 years, Neurocrine Biosciences's highest Days Payable was 1967.57. The lowest was 922.15. And the median was 1382.98.

FRA:NB3's Days Payable is ranked better than
97.37% of 949 companies
in the Drug Manufacturers industry
Industry Median: 86.4 vs FRA:NB3: 1145.46

Neurocrine Biosciences's Days Payable declined from Dec. 2023 (1,230.05) to Dec. 2024 (982.55). It may suggest that Neurocrine Biosciences accelerated paying its suppliers.

Neurocrine Biosciences Days Payable Historical Data

The historical data trend for Neurocrine Biosciences's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurocrine Biosciences Days Payable Chart

Neurocrine Biosciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Payable

Get a 7-Day Free Trial

1,531.03

1,124.26

909.20

931.26

1,277.48

Neurocrine Biosciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Payable	Get a 7-Day Free Trial															1,230.05	1,339.34	960.36	1,176.17	982.55

Competitive Comparison of Neurocrine Biosciences's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Neurocrine Biosciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neurocrine Biosciences's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Neurocrine Biosciences's Days Payable distribution charts can be found below:

* The bar in red indicates where Neurocrine Biosciences's Days Payable falls into.

Neurocrine Biosciences Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Neurocrine Biosciences's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

	Days Payable (A: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2023 )	+	Accounts Payable (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (122.236	+	105.05)	/	2 )	/	32.47	*	365
=	113.643					/	32.47	*	365
=	1,277.48

Neurocrine Biosciences's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

	Days Payable (Q: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2024 )	+	Accounts Payable (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (86.226	+	105.05)	/	2 )	/	8.8819999999999	*	365 / 4
=	95.638					/	8.8819999999999	*	365 / 4
=	982.55

Neurocrine Biosciences Days Payable Related Terms

Thank you for viewing the detailed overview of Neurocrine Biosciences's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurocrine Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurocrine Biosciences Inc (FRA:NB3) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

NBIX:USA 0K6R:UK NB3:Germany N1BI34:Brazil

Address

6027 Edgewood Bend Court, San Diego, CA, USA, 92130

Website

https://www.neurocrine.com

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

Neurocrine Biosciences Headlines

No Headlines